Description
PRINCIPIO ACTIVO: CLORIDRHATO DE DAPOXETINA
PRINCIPIO ACTIVO: DOMPERIDONA
Tratamiento de esquizofrenia en adultos
FORMA FARMACÉUTICA: 4 TABLETAS
PLENACOR LP 50/20MG CAP C20 TAKEDA PRINCIPIO ACTIVO: CLORIDRHATO DE DAPOXETINAPRINCIPIO ACTIVO: ATENOLOL NIFEDIPINA DOSIS: 50 20 MG FORMA FARMACUTICA: 20 CAPSULAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
